BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20874709)

  • 1. A new tool to dissect the function of p70 S6 kinase.
    Bilanges B; Vanhaesebroeck B
    Biochem J; 2010 Oct; 431(2):e1-3. PubMed ID: 20874709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).
    Pearce LR; Alton GR; Richter DT; Kath JC; Lingardo L; Chapman J; Hwang C; Alessi DR
    Biochem J; 2010 Oct; 431(2):245-55. PubMed ID: 20704563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinase.
    Rajan MR; Fagerholm S; Jönsson C; Kjølhede P; Turkina MV; Strålfors P
    PLoS One; 2013; 8(4):e59725. PubMed ID: 23565163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p70 S6K1 nuclear localization depends on its mTOR-mediated phosphorylation at T389, but not on its kinase activity towards S6.
    Rosner M; Schipany K; Hengstschläger M
    Amino Acids; 2012 Jun; 42(6):2251-6. PubMed ID: 21710263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of TRB3 on insulin and nutrient-stimulated hepatic p70 S6 kinase activity.
    Matsushima R; Harada N; Webster NJ; Tsutsumi YM; Nakaya Y
    J Biol Chem; 2006 Oct; 281(40):29719-29. PubMed ID: 16887816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1.
    Najafov A; Sommer EM; Axten JM; Deyoung MP; Alessi DR
    Biochem J; 2011 Jan; 433(2):357-69. PubMed ID: 21087210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726 and its effect on cell proliferation and cell cycle progress.
    Doscas ME; Williamson AJ; Usha L; Bogachkov Y; Rao GS; Xiao F; Wang Y; Ruby C; Kaufman H; Zhou J; Williams JW; Li Y; Xu X
    Neoplasia; 2014 Oct; 16(10):824-34. PubMed ID: 25379019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice.
    Shum M; Bellmann K; St-Pierre P; Marette A
    Diabetologia; 2016 Mar; 59(3):592-603. PubMed ID: 26733005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mitochondrial complex 1 by the S6K1 inhibitor PF-4708671 partly contributes to its glucose metabolic effects in muscle and liver cells.
    Shum M; Houde VP; Bellemare V; Junges Moreira R; Bellmann K; St-Pierre P; Viollet B; Foretz M; Marette A
    J Biol Chem; 2019 Aug; 294(32):12250-12260. PubMed ID: 31243102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress of p70 ribosomal protein S6 kinase inhibitors].
    Tu ZJ; Hu GY; Li QB
    Yao Xue Xue Bao; 2015 Mar; 50(3):261-71. PubMed ID: 26118103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach.
    Alam A; Khan MS; Mathur Y; Sulaimani MN; Farooqui N; Ahmad SF; Nadeem A; Yadav DK; Mohammad T
    J Biomol Struct Dyn; 2024 Jul; 42(11):5758-5769. PubMed ID: 37365756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PF-4708671 activates AMPK independently of p70S6K1 inhibition.
    Vainer GW; Saada A; Kania-Almog J; Amartely A; Bar-Tana J; Hertz R
    PLoS One; 2014; 9(9):e107364. PubMed ID: 25202971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PF-4708671, a specific inhibitor of p70 ribosomal S6 kinase 1, activates Nrf2 by promoting p62-dependent autophagic degradation of Keap1.
    Park JS; Kang DH; Lee DH; Bae SH
    Biochem Biophys Res Commun; 2015 Oct; 466(3):499-504. PubMed ID: 26381178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation.
    Lee SJ; Yang EK; Kim SG
    Mol Pharmacol; 2006 Jul; 70(1):415-25. PubMed ID: 16611854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling.
    Gao S; Duan C; Gao G; Wang X; Yang H
    Int J Biochem Cell Biol; 2015 Jul; 64():25-33. PubMed ID: 25813876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
    Julien LA; Carriere A; Moreau J; Roux PP
    Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.
    Byfield MP; Murray JT; Backer JM
    J Biol Chem; 2005 Sep; 280(38):33076-82. PubMed ID: 16049009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer.
    Shen H; Wang GC; Li X; Ge X; Wang M; Shi ZM; Bhardwaj V; Wang ZX; Zinner RG; Peiper SC; Aplin AE; Jiang BH; He J
    Oncogene; 2020 Dec; 39(49):7181-7195. PubMed ID: 33037411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Translation Control with p70 S6 Kinase 1 Inhibitors to Reverse Phenotypes in Fragile X Syndrome Mice.
    Bhattacharya A; Mamcarz M; Mullins C; Choudhury A; Boyle RG; Smith DG; Walker DW; Klann E
    Neuropsychopharmacology; 2016 Jul; 41(8):1991-2000. PubMed ID: 26708105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase.
    Tang X; Wang L; Proud CG; Downes CP
    Biochem J; 2003 Aug; 374(Pt 1):137-43. PubMed ID: 12747804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.